Connection

THOMAS KOSTEN to Immunotherapy

This is a "connection" page, showing publications THOMAS KOSTEN has written about Immunotherapy.
Connection Strength

2.414
  1. Current status of immunotherapies for addiction. Ann N Y Acad Sci. 2021 04; 1489(1):3-16.
    View in: PubMed
    Score: 0.439
  2. Psychopharmacology: neuroimmune signaling in psychiatric disease-developing vaccines against abused drugs using toll-like receptor agonists. Psychopharmacology (Berl). 2019 Oct; 236(10):2899-2907.
    View in: PubMed
    Score: 0.407
  3. The future potential for cocaine vaccines. Expert Opin Biol Ther. 2014 Sep; 14(9):1271-83.
    View in: PubMed
    Score: 0.293
  4. Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug Alcohol Depend. 2014 Jul 01; 140:42-7.
    View in: PubMed
    Score: 0.292
  5. Immunotherapy for drug abuse. CNS Neurol Disord Drug Targets. 2011 Dec; 10(8):876-9.
    View in: PubMed
    Score: 0.247
  6. Immunotherapy for the treatment of drug abuse. Pharmacol Ther. 2005 Oct; 108(1):76-85.
    View in: PubMed
    Score: 0.161
  7. Novel approaches to the treatment of cocaine addiction. CNS Drugs. 2005; 19(1):13-25.
    View in: PubMed
    Score: 0.153
  8. Future of anti-addiction vaccines. Stud Health Technol Inform. 2005; 118:177-85.
    View in: PubMed
    Score: 0.153
  9. Vaccines as Immunotherapies for Substance Use Disorders. Am J Psychiatry. 2024 May 01; 181(5):362-371.
    View in: PubMed
    Score: 0.146
  10. Vaccines against stimulants: cocaine and MA. Br J Clin Pharmacol. 2014 Feb; 77(2):368-74.
    View in: PubMed
    Score: 0.072
  11. Therapeutic vaccines for substance dependence. Expert Rev Vaccines. 2002 Oct; 1(3):363-71.
    View in: PubMed
    Score: 0.033
  12. Probing cocaine-antibody interactions in buffer and human serum. PLoS One. 2012; 7(7):e40518.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.